Abstract:The production of N -linked glycoproteins in genetically engineered Escherichia coli holds significant potential for reducing costs, streamlining bioprocesses, and enhancing customization. However, the construction of a stable and low-cost microbial cell factory for the efficient production of humanized N -glycosylated recombinant proteins remains a formidable challenge. In this study, we developed a glyco-engineered E. coli chassis to produce N -glycosylated proteins with the human-like glycan Gal-β-1,4-GlcNAc-β-1,3-Gal-β-1,3-GlcNAc-, containing the human glycoform Gal-β-1,4-GlcNAc-β-1,3-. Our initial efforts were to replace various loci in the genome of the E. coli XL1-Blue strain with oligosaccharyltransferase PglB and the glycosyltransferases LsgCDEF to construct the E. coli chassis. In addition, we systematically optimized the promoter regions in the genome to regulate transcription levels. Subsequently, utilizing a plasmid carrying the target protein, we have successfully obtained N -glycosylated proteins with 100% tetrasaccharide modification at a yield of approximately 320 mg/L. Furthermore, we constructed the metabolic pathway for sialylation using a plasmid containing a dual-expression cassette of the target protein and CMP-sialic acid synthesis in the tetrasaccharide chassis cell, resulting in a 40% efficiency of terminal α-2,3- sialylation and a production of 65 mg/L of homogeneously sialylated glycoproteins in flasks. Our findings pave the way for further exploration of producing different linkages (α-2,3/α-2,6/α-2,8) of sialylated human-like N -glycoproteins in the periplasm of the plug-and-play E. coli chassis, laying a strong foundation for industrial-scale production.

Preparation of Unglycosylated Human Caseinomacropeptide by Engineering DAB Escherichia Coli.

Quantitative determination of bovine caseinoglycomacropeptide in infant formulas by ultra-high-performance liquid chromatography-electrospray-ionization mass spectrometry.

Refolding and two-step purification by hydrophobic interaction chromatography of recombinant human bone morphogenetic protein-2 from Escherichia coli

Human Proinsulin C-Peptide from A Precursor Overexpressed in Pichia Pastoris

Enrichment of sialic acid-containing casein glycomacropeptide in protein hydrolysates using phenylboronic acid-functionalized mesoporous silica nanoparticles

High-level expression and purification of human creatine kinase MM isozymes in E.coli

High‐level secretory expression and purification of unhydroxylated human collagen α1(III) chain in Pichia pastoris GS115

Preparation and High Performance Liquid Chromatographic Separation of Casein Peptides

Chaperonin co-expression and chemical modification enables production of active microbial transglutaminase from E. coli cytoplasm

Expression and purification of soluble human cystatin C in Escherichia coli with maltose-binding protein as a soluble partner.

Prokaryotic Expression and Functional Study of a Novel Recombinant Human-derived Collagen

High cell density cultivation of recombinant Escherichia coli for prodrug of recombinant human GLPs production

Purification of a recombinant human growth hormone by an integrated IMAC procedure

Production of Human Insulin in an E. Coli System with Met-Lys-human Proinsulin As the Expressed Precursor.

The whole-cell immobilization of d-hydantoinase-engineered Escherichia coli for d-CpHPG biosynthesis

Construction of Met-Lys-double-C peptide human proinsulin gene and its expression and characterization

Expression, Purification, and Characterization of His-tagged Penicillin G Acylase from Kluyvera Citrophila in Escherichia Coli.

[Preparation and characterization of recombinant human-source collagen]

One-Step Purification of a Fusion Protein of Glucagon-Like Peptide-1 and Human Serum Albumin Expressed in Pichia pastoris by an Immunomagnetic Separation Technique

Development of a full-length human protein production pipeline

Construction of an Escherichia coli chassis for efficient biosynthesis of human-like N-linked glycoproteins